NIAID Banner Logo Image

HIV Citations List: March, 2017

Literature Citations

1. Toll-like Receptor 3 Activation Selectively Reverses HIV Latency in Microglial Cells. Alvarez-Carbonell, D., Y. Garcia-Mesa, S. Milne, B. Das, C. Dobrowolski, R. Rojas, and J. Karn. Retrovirology, 2017. 14(9): 25pp. PMID[28166799]. PMCID[PMC5294768].

[PubMed]. HIV_03_2017.


2. Computational Identification of Novel Entry Inhibitor Scaffolds Mimicking Primary Receptor CD4 of HIV-1 gp120. Andrianov, A.M., I.A. Kashyn, and A.V. Tuzikov. Journal of Molecular Modeling, 2017. 23(18). PMID[28050723].

[PubMed]. HIV_03_2017.


3. Identification of Small Molecule Modulators of HIV-1 Tat and Rev Protein Accumulation. Balachandran, A., R. Wong, P. Stoilov, S. Pan, B. Blencowe, P. Cheung, P.R. Harrigan, and A. Cochrane. Retrovirology, 2017. 14(7): 21pp. PMID[28122580]. PMCID[PMC5267425].

[PubMed]. HIV_03_2017.


4. Induced Packaging of Cellular MicroRNAs into HIV-1 Virions Can Inhibit Infectivity. Bogerd, H.P., E.M. Kennedy, A.W. Whisnant, and B.R. Cullen. mBio, 2017. 8(1): e02125-16. PMID[28096489].

PMCID[PMC5241401].

[PubMed]. HIV_03_2017.


5. MZC Gel Inhibits SHIV-RT and HSV-2 in Macaque Vaginal Mucosa and SHIV-RT in Rectal Mucosa. Calenda, G., G. Villegas, P. Barnable, C. Litterst, K. Levendosky, A. Gettie, M.L. Cooney, J. Blanchard, J.A. Fernandez-Romero, T.M. Zydowsky, and N. Teleshova. Journal of Acquired Immune Deficiency Syndromes (1999), 2017. 74(3): p. e67-e74. PMID[27552154]. PMCID[PMC5303173].

[PubMed]. HIV_03_2017.


6. Ga(III) Nanoparticles Inhibit Growth of Both Mycobacterium Tuberculosis and HIV and Release of Interleukin-6 (IL-6) and IL-8 in Coinfected Macrophages. Choi, S.R., B.E. Britigan, and P. Narayanasamy. Antimicrobial Agents and Chemotherapy, 2017. 61(4): e02505-16. PMID[28167548].

[PubMed]. HIV_03_2017.


7. Acetone and Methanol Fruit Extracts of Terminalia paniculata Inhibit HIV-1 Infection in Vitro.Durge, A., P. Jadaun, A. Wadhwani, A.A. Chinchansure, M. Said, H.V. Thulasiram, S.P. Joshi, and S.S. Kulkarni. Natural Product Research, 2017. 31(12): p. 1468-1471. PMID[27868445].

[PubMed]. HIV_03_2017.


8. Insights into the Activity of Maturation Inhibitor PF-46396 on HIV-1 Clade C. Ghimire, D., U. Timilsina, T.P. Srivastava, and R. Gaur. Scientific Reports, 2017. 7(43711): 10pp. PMID[28252110]. PMCID[PMC5333120].

[PubMed]. HIV_03_2017.


9. Autophagy Facilitates Macrophage Depots of Sustained-release Nanoformulated Antiretroviral Drugs.Gnanadhas, D.P., P.K. Dash, B. Sillman, A.N. Bade, Z. Lin, D.L. Palandri, N. Gautam, Y. Alnouti, H.A. Gelbard, J. McMillan, R.L. Mosley, B. Edagwa, H.E. Gendelman, and S. Gorantla. The Journal of Clinical Investigation, 2017. 127(3): p. 857-873. PMID[28134625]. PMCID[PMC5330738].

[PubMed]. HIV_03_2017.


10. Antibody Therapy Paired with Antiretroviral Therapy Suppresses Viral Load Long Term in SIV-macaques, Even after Treatment Stops. Harper, K.N. AIDS, 2017. 31(4): p. N7-N8. PMID[28002064].

[PubMed]. HIV_03_2017.


11. Mangrove-mediated Green Synthesis of Silver Nanoparticles with High HIV-1 Reverse Transcriptase Inhibitory Potential. Kumar, S.D., G. Singaravelu, S. Ajithkumar, K. Murugan, M. Nicoletti, and G. Benelli. Journal of Cluster Science, 2017. 28(1): p. 359-367. ISI[000394325800023].

[WOS]. HIV_03_2017.


12. Combinational CRISPR/Cas9 Gene-editing Approach Can Halt HIV Replication and Prevent Viral Escape. Lebbink, R.J., D.C.M. de Jong, F. Wolters, E.M. Kruse, P.M. van Ham, E.J.H.J. Wiertz, and M. Nijhuis. Scientific Reports, 2017. 7(41968). 10pp. PMID[28176813]. PMCID[PMC5296774].

[PubMed]. HIV_03_2017.


13. Structure-Activity Relationship Studies on a Trp Dendrimer with Dual Activities against HIV and Enterovirus A71. Modifications on the Amino acid.Martinez-Gualda, B., L. Sun, E. Rivero-Buceta, A. Flores, E. Quesada, J. Balzarini, S. Noppen, S. Liekens, D. Schols, J. Neyts, P. Leyssen, C. Mirabelli, M.J. Camarasa, and A. San-Felix. Antiviral Research, 2017. 139: p. 32-40. PMID[28017762].

[PubMed]. HIV_03_2017.


14. Identification of Binding Mode and Prospective Structural Features of Novel Nef Protein Inhibitors as Potential anti-HIV Drugs. Moonsamy, S., S. Bhakat, M. Ramesh, and M.E. Soliman. Cell Biochemistry and Biophysics, 2017. 75(1): p. 49-64. PMID[27981421].

[PubMed]. HIV_03_2017.


15. Multiple Histone Lysine Methyltransferases Are Required for the Establishment and Maintenance of HIV-1 Latency. Nguyen, K., B. Das, C. Dobrowolski, and J. Karn. mBio, 2017. 8(1): e00133-17. PMID[28246360]. PMCID[PMC5347344].

[PubMed]. HIV_03_2017.


16. Early Antibody Therapy Can Induce Long-lasting Immunity to SHIV. Nishimura, Y., R. Gautam, T.W. Chun, R. Sadjadpour, K.E. Foulds, M. Shingai, F. Klein, A. Gazumyan, J. Golijanin, M. Donaldson, O.K. Donau, R.J. Plishka, A. Buckler-White, M.S. Seaman, J.D. Lifson, R.A. Koup, A.S. Fauci, M.C. Nussenzweig, and M.A. Martin. Nature, 2017. 543(7646): p. 559-563. PMID[28289286].

[PubMed]. HIV_03_2017.


17. Administration of Nucleoside-modified mRNA Encoding Broadly Neutralizing Antibody Protects Humanized Mice from HIV-1 Challenge. Pardi, N., A.J. Secreto, X. Shan, F. Debonera, J. Glover, Y. Yi, H. Muramatsu, H. Ni, B.L. Mui, Y.K. Tam, F. Shaheen, R.G. Collman, K. Kariko, G.A. Danet-Desnoyers, T.D. Madden, M.J. Hope, and D. Weissman. Nature Communications, 2017. 8: p. 14630. PMID[28251988]. PMCID[PMC5337964].

[PubMed]. HIV_03_2017.


18. Macrocyclic Peptidomimetics Prepared by Ring-closing Metathesis and Azide-alkyne Cycloaddition.Pehere, A.D., X. Zhang, and A.D. Abell. Australian Journal of Chemistry, 2017. 70(2): p. 138-151. ISI[000395050500004].

[WOS]. HIV_03_2017.


19. Reassessing APOBEC3G Inhibition by HIV-1 Vif-Derived Peptides. Richards, C.M., M. Li, A.L. Perkins, A. Rathore, D.A. Harki, and R.S. Harris. Journal of Molecular Biology, 2017. 429(1): p. 88-96. PMID[27887868]. PMCID[PMC5186364].

[PubMed]. HIV_03_2017.


20. A Mutant Tat Protein Inhibits Infection of Human Cells by Strains from Diverse HIV-1 Subtypes.Rustanti, L., H. Jin, M. Lor, M.H. Lin, D.J. Rawle, and D. Harrich. Virology Journal, 2017. 14(1): p. 52. PMID[28288662]. PMCID[PMC5348743].

[PubMed]. HIV_03_2017.


21. Quantitative Structure-Cytotoxicity Relationship of Chalcones. Sakagami, H., Y. Masuda, M. Tomomura, S. Yokose, Y. Uesawa, N. Ikezoe, D. Asahara, K. Takao, T. Kanamoto, S. Terakubo, H. Kagaya, H. Nakashima, and Y. Sugita. Anticancer Research, 2017. 37(3): p. 1091-1098. PMID[28314269].

[PubMed]. HIV_03_2017.


22. Novel Dioxolan Derivatives of Indole as HIV-1 Integrase Strand Transfer Inhibitors Active against RAL Resistant Mutant Virus. Singh, R., P. Yadav, Urvashi, and V. Tandon. ChemistrySelect, 2016. 1(17): p. 5471-5478. ISI[000395425400012].

[WOS]. HIV_03_2017.


23. Evaluation of Combination Long-acting Nanoformulated Antiretroviral Therapy in Early HIV-1 Infected Hupbl Nod.Cg-Prkdcscid Il2rgtm1wjl/Szj Mice. Su, H., P. Dash, M. Arainga, B. Edagwa, J. McMillan, L. Poluektova, S. Gorantla, and H. Gendelman. Journal of Neurovirology, 2016. 22: p. S74-S75. ISI[000394093700154].

[WOS]. HIV_03_2017.


24. Creating an Artificial Tail Anchor as a Novel Strategy to Enhance the Potency of Peptide-based HIV Fusion Inhibitors. Su, S., Y. Zhu, S. Ye, Q. Qi, S. Xia, Z. Ma, F. Yu, Q. Wang, R. Zhang, S. Jiang, and L. Lu. Journal of Virology, 2017. 91(1): e01445-16. PMID[27795416]. PMCID[PMC5165219].

[PubMed]. HIV_03_2017.


25. Synthesis and Biological Activities of Ethyl 2-(2-Pyridylacetate) Derivatives Containing Thiourea, 1,2,4-Triazole, Thiadiazole and Oxadiazole Moieties. Szulczyk, D., P. Tomaszewski, M. Jozwiak, A.E. Koziol, T. Lis, D. Collu, F. Iuliano, and M. Struga. Molecules, 2017. 22(409): 16pp. PMID[28272311].

[PubMed]. HIV_03_2017.


26. 6-Cyclohexylmethyl-3-hydroxypyrimidine-2,4-dione as an Inhibitor Scaffold of HIV Reverase Transcriptase: Impacts of the 3-OH on Inhibiting RNase H and Polymerase. Tang, J., K.A. Kirby, A.D. Huber, M.C. Casey, J. Ji, D.J. Wilson, S.G. Sarafianos, and Z. Wang. European Journal of Medicinal Chemistry, 2017. 128: p. 168-179. PMID[28182989]. PMCID[PMC5384110].

[PubMed]. HIV_03_2017.


27. Inhibition of HIV-1 Gag-membrane Interactions by Specific RNAs. Todd, G.C., A. Duchon, J. Inlora, E.D. Olson, K. Musier-Forsyth, and A. Ono. RNA, 2017. 23(3): p. 395-405. PMID[27932583]. PMCID[PMC5311501].

[PubMed]. HIV_03_2017.


28. Toll-like Receptor 7 Agonist GS-9620 Induces HIV Expression and HIV-specific Immunity in Cells from HIV-infected Individuals on Suppressive Antiretroviral Therapy. Tsai, A., A. Irrinki, J. Kaur, T. Cihlar, G. Kukolj, D.D. Sloan, and J.P. Murry. Journal of Virology, 2017. 91(8):e02166-16 . PMID[28179531].

[PubMed]. HIV_03_2017.


29. Conjugates of Phosphorylated Zalcitabine and Lamivudine with SiO2 Nanoparticles: Synthesis by CuAAC Click Chemistry and Preliminary Assessment of anti-HIV and Antiproliferative Activity. Vasilyeva, S.V., A.A. Shtil, A.S. Petrova, S.M. Balakhnin, P.Y. Achigecheva, D.A. Stetsenko, and V.N. Silnikov. Bioorganic & Medicinal Chemistry, 2017. 25(5): p. 1696-1702. PMID[28169081].

[PubMed]. HIV_03_2017.


30. IFN-lambda Inhibits Drug-resistant HIV Infection of Macrophages. Wang, X., H. Wang, M.Q. Liu, J.L. Li, R.H. Zhou, Y. Zhou, Y.Z. Wang, W. Zhou, and W.Z. Ho. Frontiers in Immunology, 2017. 8(210): 8pp. PMID[28321215]. PMCID[PMC5337814].

[PubMed]. HIV_03_2017.


31. Development of a Novel Formulation That Improves Preclinical Bioavailability of Tenofovir Disoproxil Fumarate. Watkins, M.E., S. Wring, R. Randolph, S. Park, K. Powell, L. Lutz, M. Nowakowski, R. Ramabhadran, and P.L. Domanico. Journal of Pharmaceutical Sciences, 2017. 106(3): p. 906-919. PMID[27986599]. PMCID[PMC5320394].

[PubMed]. HIV_03_2017.


32. Griseofulvin Derivative and Indole Alkaloids from Penicillium griseofulvum CPCC 400528. Zhang, D., L. Zhao, L. Wang, X. Fang, J. Zhao, X. Wang, L. Li, H. Liu, Y. Wei, X. You, S. Cen, and L. Yu. Journal of Natural Products, 2017. 80(2): p. 371-376. PMID[28117586].

[PubMed]. HIV_03_2017.


33. Discovery of Uracil-bearing DAPYs Derivatives as Novel HIV-1 NNRTIS via Crystallographic Overlay-based Molecular Hybridization. Zhang, H., Y. Tian, D. Kang, Z. Huo, Z. Zhou, H. Liu, E. De Clercq, C. Pannecouque, P. Zhan, and X. Liu. European Journal of Medicinal Chemistry, 2017. 130: p. 209-222. PMID[28254696].

[PubMed]. HIV_03_2017.


Patent Citations

34. Substituted Phenylpyrrolecarboxamides with Therapeutic Activity in HIV Infection. Debnath, A.K., F. Curreli, P.D. Kwong, and Y.D. Kwon. Patent. 2017. 2016-US48151 2017035127: 99pp.

[Patent]. HIV_03_2017.


35. 5-(N-Benzyltetrahydroisoquinolin-6-yl)pyridin-3-ylacetic acid Derivatives as Inhibitors of Human Immunodeficiency Virus Replication and Their Preparation. Eastman, K.J., J.F. Kadow, K.E. Parcella, B.N. Naidu, T. Wang, Z. Yin, and Z. Zhang. Patent. 2017. 2016-IB54832 2017025917: 121pp.

[Patent]. HIV_03_2017.


36. Preparation of 4'-Substituted Nucleosides and Nucleotide Triphosphates as Reverse Transcriptase Inhibitors. Girijavallabhan, V.M., M. McLughlin, E. Cleator, J. Kong, A.W. Gibson, D.R. Lieberman, A. Dieguez Vazquez, S.P. Keen, M.J. Williams, J.C. Moore, E.M. Milczek, F. Peng, K.M. Belyk, and Z.J. Song. Patent. 2017. 2016-US52409 2017053216: 70pp.

[Patent]. HIV_03_2017.


37. Imidazopyridine Macrocycles as Inhibitors of Human Immunodeficiency Virus Replication and Their Preparation. Kadow, J.F., B.N. Naidu, M. Patel, K. Peese, and Z. Wang. Patent. 2017. 2016-IB54827 2017025913: 111pp.

[Patent]. HIV_03_2017.


38. Pyridin-3-yl acetic acid Derivatives as Inhibitors of Human Immunodeficiency Virus Replication and Their Preparation. Kadow, J.F., B.N. Naidu, and Y. Tu. Patent. 2017. 2016-IB54944 2017029631: 133pp.

[Patent]. HIV_03_2017.


39. 5-(N-Aryltetrahydroisoquinolin-6-yl)pyridin-3-ylacetic acid Derivatives as Inhibitors of Human Immunodeficiency Virus Replication and Their Preparation. Kadow, J.F., B.N. Naidu, T. Wang, Z. Yin, and Z. Zhang. Patent. 2017. 2016-IB54831 2017025916: 62pp.

[Patent]. HIV_03_2017.


40. 5-(N-Substituted tetrahydroisoquinolin-6-yl)pyridin-3-ylacetic acid Derivatives as Inhibitors of Human Immunodeficiency Virus Replication and Their Preparation. Kadow, J.F., B.N. Naidu, T. Wang, Z. Yin, and Z. Zhang. Patent. 2017. 2016-IB54829 2017025914: 62pp.

[Patent]. HIV_03_2017.


41. Preparation of Novel C28-Analogues with C3-Modifications of Triterpene Derivatives as HIV Inhibitors. Reddy, B.P., K.R. Reddy, G.L.D. Krupadanam, A.P. Reddy, and M. Venkati. Patent. 2017. 2016-IB54804 2017025901: 78pp.

[Patent]. HIV_03_2017.

If using ChemDB information for publication or abstract presentation, please cite the website in addition to the original information source.    Database last updated: September 2021